Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00884871 · ClinicalTrials.gov registry record

Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders

A clinical trial of Pelvic Floor Disorders, sponsored by University of California, San Diego.

Completed
Registry status
100
Enrollment target
1
Study location

NCT00884871 is a study of Pelvic Floor Disorders that has completed, run by University of California, San Diego. The registered enrollment target is 100 participants, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00884871, a study of Pelvic Floor Disorders, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in severely, morbidly and super-obese women using a prospective, observational study design.

Conditions Studied

Interventions

  • PROCEDURE LapBand

Study Locations (1)

California

  • University of California San Diego Medical Center - La Jolla

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-09
Est. Completion 2009-11

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT00884871

The ClinicalTrials.gov registry entry for NCT00884871 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 107-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 1 intervention - of which LapBand is the first listed.

NCT00884871 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00884871 about?

NCT00884871 is a clinical study titled "Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders". The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in sever...

What is the current status of trial NCT00884871?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-09. Estimated completion is 2009-11.

What conditions does trial NCT00884871 study?

This clinical trial studies the following conditions: Pelvic Floor Disorders.

What interventions are being tested in trial NCT00884871?

The interventions under investigation include: LapBand (PROCEDURE).

Who is sponsoring clinical trial NCT00884871?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00884871 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Floor Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.